Written Question · S1W-04958 · Session 1
Further to the answer to question S1W-3393 by Susan Deacon on 16 February 2000, what plans it has to ensure that individual health boards a…
The question
To ask the Scottish Executive, further to the answer to question S1W-3393 by Susan Deacon on 16 February 2000, what plans it has to ensure that individual health boards are following the Scottish Medical Advisory Committee's guidance about new drugs for multiple sclerosis and clinical advice, issued to all health boards in 1995.
The answer
The Scottish Medical Advisory Committee's guidance about new drugs for the treatment of relapsing-remitting multiple sclerosis continues to apply. The implementation of that guidance is a matter for each health board.
In the Official Report
No contribution in the Official Report cites S1W-04958 by reference.